We are seeing a reduction, rather drastic — our hospital started monoclonals at the hospital with a direct referral from the ER for outpatient infusion once diagnosed and administered immediately — We are seeing a dramatic decrease in hospitalization and critical illness.
I would like your opinion — if getting a booster, would you get the other product — IE if you had Pfizer would you boost with moderna and vice versa, or would you get the same series. I am including Jim Nobel on this question because IIRC he weighed in on it.
Well of course you’re the one with medical training. Do you have a view?
Under the model of why vaccines work, does one want to diversify or strengthen the existing arsenal?
The monoclonal antibodies are very good and I give a lot.
I still have zero deaths of vaccinated pts. It happens but not to me so far.
I asked my ID colleague/friend that question. His response? Who knows. I guess same one since I had Pfizer. Moderna not cleared for booster yet but will be. Pfizer is what my office has, too.
What you think? Might also make sense to produce a different immune response.
I don’t know enough about the coding of the mRNA in Pfizer v. Moderna to have an opinion about whether an « opposite » dose #3 would broaden your response to a new infection.
I got Pfizer and I’m planning to get #3 as Pfizer also.
By the way, I’m not thinking of the third dose as a booster but rather as completion of the primary series. If the graphene doesn’t get me I should be good to go.
When I get my booster I’m requesting extra graphene oxide but hold the onions please……….👨🏻🔬🧅